| Figure 3. |
|
|
| Mean regulatory review phase (new drug application [NDA] phase) time for psychotropic and other NCEs approved in the United States during 1963 to 1993 and 1994 to 1997. The NDA phase is the time from NDA submission to NDA approval. |
published 2000